Tuesday, July 1, 2025 7/1/2025

The Role of the Gut Microbiome in Post-Sepsis Skeletal Muscle Atrophy

Award Number: K08AR083015
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 04/01/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2029

Group Awards By:

View Award Description

The Role of the Gut Microbiome in Post-Sepsis Skeletal Muscle Atrophy - PROJECT SUMMARY This K08 proposal outlines the plan for Kale Bongers, M.D. Ph.D.’s to complete training toward his long-term goal of improving our understanding of post-sepsis muscle atrophy and weakness through investigation of the microbiome. Dr. Bongers is a physician-scientist in Pulmonary and Critical Care Medicine at the University of Michigan with an established record of success in skeletal muscle biology and microbiome studies. This proposal builds on Dr. Bongers’ previously acquired skillset in skeletal muscle biology, critical illness pathophysiology, and microbial ecology with new training in metabolomics and metagenomics. These skills will be integrated to improve our understanding of the role of the gut microbiome in mediating skeletal muscle atrophy after sepsis. This research will be conducted under the guidance of mentor Robert Dickson, M.D., co- mentor Kathleen Stringer, Pharm.D., and an advisory board of renowned investigators with experience in metabolomics, microbial ecology, microbiome studies, skeletal muscle in critical illness, and sepsis pathophysiology. The five-year plan includes intensive mentorship, formal didactic coursework, professional development, and increasingly independent research, with milestones to encourage productive research output and transition to independence. Sepsis is a common and deadly condition of organ dysfunction and immune dysregulation secondary to infection that often leaves its survivors severely debilitated due to muscle atrophy. Studies have suggested that the gut microbiome plays a critical role in the regulation of skeletal muscle size and strength, but to date no study has evaluated the role of the gut microbiome in the pathogenesis of post- sepsis skeletal muscle atrophy. This proposal tests the hypothesis that the gut microbiome plays a critical role in post-sepsis skeletal muscle atrophy via two specific Aims. Aim 1 will identify the key bacterial taxa that contribute to or prevent muscle atrophy in multiple models of murine sepsis, while Aim 2 will identify key bacterially-derived metabolites that mediate these changes in muscle. To accomplish these Aims, Dr. Bongers will leverage both in vivo and in vitro models of skeletal muscle with cutting-edge techniques in metabolomics and metagenomics to identify and mechanistically interrogate how gut bacteria influence skeletal muscle size and function during sepsis. This will lay crucial groundwork for future R01 proposals to 1) determine whether supplementation of key bacteria or key bacterially-derived metabolites can prevent skeletal muscle atrophy and 2) translate these findings to humans using morphomics and pre-existing bacterial swabs. In addition to building a strong line of research to understand the role of the microbiome in muscle atrophy, this proposal will provide Dr. Bongers with new research skills applicable to microbiome and metabolomics research. This K08 award will enable Dr. Bongers to establish himself as an independent physician-scientist and rising leader in this important field.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $166,428 )
2025	2025	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Arthritis, Musculoskeletal and Skin Diseases Research	004	3	3/13/2025	NON-COMPETING CONTINUATION	$166,428
2025	2024	REGENTS OF THE UNIVERSITY OF MICHIGAN	1109 GEDDES AVE STE 3300	ANN ARBOR	MI	48109	WASHTENAW	USA	Arthritis, Musculoskeletal and Skin Diseases Research	002	1	2/27/2025	NEW	-$1,678
2025	2024	REGENTS OF THE UNIVERSITY OF MICHIGAN	1109 GEDDES AVE, SUITE 3300	ANN ARBOR	MI	48109	WASHTENAW	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	10/24/2024	NEW	-$138,518
2025	2024	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Arthritis, Musculoskeletal and Skin Diseases Research	003	2	2/27/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$1,678
2025	2024	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	10/25/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$138,518
														Subtotal = $166,428

Issue Date FY: 2024 ( Subtotal = $174,365 )
2024	2024	REGENTS OF THE UNIVERSITY OF MICHIGAN	1109 GEDDES AVE, SUITE 3300	ANN ARBOR	MI	48109	WASHTENAW	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	3/28/2024	NEW	$174,365
														Subtotal = $174,365

Grand Total All Awards = $340,793

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of the Gut Microbiome in Post-Sepsis Skeletal Muscle Atrophy

Award Number: K08AR083015

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 04/01/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer